p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer
1999

The Role of p21/WAF1 in Ovarian Cancer

Sample size: 316 publication Evidence: moderate

Author Information

Author(s): Anttila M A, Kosma V-M, Hongxiu J, Puolakka J, Juhola M, Saarikoski S, Syrjänen K

Primary Institution: Kuopio University Hospital

Hypothesis

The expression of p21/WAF1 is related to p53, cell proliferation, and prognosis in epithelial ovarian cancer.

Conclusion

Low p21/WAF1 expression is associated with poor survival outcomes in patients with epithelial ovarian cancer.

Supporting Evidence

  • Low p21/WAF1 expression was significantly associated with high grade of the tumour.
  • Low p21/WAF1 expression was associated with advanced FIGO stage.
  • Low p21/WAF1 expression was a marker of poor overall survival.
  • Patients with p21–/p53+ tumours had poorer overall and recurrence-free survival.
  • p21/p53 expression independently predicted tumour recurrence.

Takeaway

This study found that low levels of a protein called p21/WAF1 in ovarian cancer can mean the cancer is more aggressive and harder to treat.

Methodology

Immunohistochemical assessment of p21/WAF1 expression in ovarian cancer samples.

Statistical Information

P-Value

P = 0.0005

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6690298

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication